ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,384 | -62.8% | 62,071 | -45.6% | 0.00% | – |
| Q2 2023 | $336,820 | -58.1% | 114,176 | -64.5% | 0.00% | – |
| Q1 2023 | $803,445 | +62.6% | 321,377 | +106.2% | 0.00% | – |
| Q4 2022 | $494,144 | -15.7% | 155,881 | -21.0% | 0.00% | – |
| Q3 2022 | $586,000 | +190.1% | 197,298 | +198.4% | 0.00% | – |
| Q2 2022 | $202,000 | -78.3% | 66,122 | -3.9% | 0.00% | – |
| Q1 2022 | $929,000 | -23.3% | 68,792 | -26.0% | 0.00% | – |
| Q4 2021 | $1,211,000 | -27.8% | 92,919 | -48.0% | 0.00% | – |
| Q3 2021 | $1,677,000 | -40.8% | 178,773 | -35.4% | 0.00% | – |
| Q2 2021 | $2,831,000 | +585.5% | 276,538 | +1132.1% | 0.00% | – |
| Q1 2021 | $413,000 | -30.0% | 22,445 | +30.4% | 0.00% | – |
| Q4 2020 | $590,000 | +2581.8% | 17,215 | +1334.6% | 0.00% | – |
| Q3 2020 | $22,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |